Morgan Stanley Maintains Equal-Weight on Exelixis, Raises Price Target to $23
Portfolio Pulse from Benzinga Newsdesk
Morgan Stanley analyst Jefferson Harralson has maintained an Equal-Weight rating on Exelixis (NASDAQ:EXEL) and raised the price target from $22 to $23.
November 02, 2023 | 4:22 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Morgan Stanley has maintained an Equal-Weight rating on Exelixis and raised the price target from $22 to $23, which could potentially attract investors.
The raised price target by Morgan Stanley indicates a positive outlook for Exelixis. This could potentially attract investors, leading to an increase in the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100